This inventor holds 1 USPTO granted patent. Top assignees: Szegedi Biológiai Kutatóközpont, Univerza V Ljubljani. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Lucija Peterlin Mašič: Innovator in Antibiotic Development
Introduction
Lucija Peterlin Mašič is a prominent inventor based in Medvode, Slovenia. She has made significant contributions to the field of antibiotic development, particularly through her innovative research on DNA gyrase and topoisomerase IV inhibitors. Her work focuses on creating effective treatments for bacterial infections, which is crucial for both human health and veterinary medicine.
Latest Patents
Lucija holds a patent for a class of DNA gyrase and/or topoisomerase IV inhibitors with activity against gram-positive and gram-negative bacteria. The patent describes compounds with a general formula (I), detailing processes for their preparation and pharmaceutical compositions that contain these compounds as active ingredients. This invention is aimed at treating bacterial infections in humans and warm-blooded animals, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Lucija has worked with notable institutions, including the University of Ljubljana and the Szegedi Biological Research Center. Her research has not only contributed to the scientific community but has also paved the way for new therapeutic options in the fight against bacterial infections.
Collaborations
Lucija has collaborated with esteemed colleagues such as Tihomir Tomašič and Nace Zidar. These partnerships have enhanced her research efforts and have been instrumental in the development of her patented inventions.
Conclusion
Lucija Peterlin Mašič is a trailblazer in the field of antibiotic research, with a focus on innovative solutions to combat bacterial infections. Her contributions through her patent and collaborations highlight her dedication to improving health outcomes for both humans and animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile